EQS-News: Limes Schlosskliniken AG: LIMES Schlosskliniken AG increases stake in Swiss clinic PRC Group AG
EQS-News: Limes Schlosskliniken AG
/ Key word(s): Investment/Investment
Limes Schlosskliniken AG: LIMES Schlosskliniken AG increases stake in Swiss clinic PRC Group AG
22.06.2023 / 08:47 CET/CEST
The issuer is solely responsible for the content of this announcement.
DGAP-Corporate News: LIMES Schlosskliniken AG:
LIMES Schlosskliniken AG increases stake in Swiss clinic PRC Group AG
LIMES Schlosskliniken AG, Cologne, 22.06.2023. LIMES Schlosskliniken AG has acquired a further
5 percent of the Swiss PRC Group AG. The remaining 44 percent are held by the management of the Paracelsus Group. This brings the total shareholding of Limes Schlosskliniken AG in the PRC Group to 56 percent.
PRC Group operates the world's most exclusive, individualized and discreet clinic for addiction and mental illness under the name Paracelsus Recovery. With teams of 15 doctors and therapists per patient, it treats mainly international UHNW clientele and prominent patients at its locations in Zurich and London.
The financing of the transaction follows from liquid funds of the LIMES Group.
Company profiles:
Paracelsus Recovery was founded in 2013 as a family-owned clinic and has established itself as the world’s leading clinic for addiction and mental illness. Besides its base in Zürich, since 2019 the clinic also treats patients in London. Furthermore, the clinic sends individual therapists and whole teams to support patients worldwide in their homes. The exclusive treatment offers are catering to an affluent international clientele such as business owners, top executives and public figures, as well as their family members, who seek not only the best possible and most intensive treatment options, but require strict confidentiality and a luxurious environment. More information can be found at www.paracelsus-recovery.com.
The LIMES Schlosskliniken Group operates high-quality private clinics in Germany for stress-related illnesses, mental and emotional disorders, such as depression, affective disorders and acute burnout conditions. The range of services is aimed at private patients, those entitled to state aid and self-payers. The LIMES Schlosskliniken Group stands for the special approach of a relationship-oriented medicine in the treatment of people with mental illnesses. In addition to top medical quality, patients are offered a unique, protected and healing environment in which they can recover holistically. Further information is available at www.limes-schlosskliniken.de.
Your contact person:
LIMES Schlosskliniken AG, Petra Kaes, Investor Relations
Kaiser-Wilhelm-Ring 26, 50672 Cologne
Tel.: 0221/669 615 10, [email protected]
Language: German
Company: LIMES Schlosskliniken AG, Kaiser-Wilhelm-Ring 26, 50672 Cologne, Germany
Phone: 49 221 669 615 10
Mail: [email protected]
Internet: www.limes-schlosskliniken.de
ISIN: DE000A0JDBC7
WKN: AOJDBC
Stock exchange: Düsseldorf Open Market, Primary Market, XETRA
End of the message
22.06.2023 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.
The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.eqs-news.com
|
Language: |
English |
Company: |
Limes Schlosskliniken AG |
|
Kaiser-Wilhelm-Ring 26 |
|
50672 Köln |
|
Germany |
ISIN: |
DE000A0JDBC7 |
WKN: |
A0JDBC |
Listed: |
Regulated Unofficial Market in Dusseldorf |
EQS News ID: |
1662735 |
|
End of News |
EQS News Service |
1662735 22.06.2023 CET/CEST
Die wichtigsten Finanzdaten auf einen Blick
|
|
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
Umsatzerlöse1 |
6,54 |
7,43 |
8,18 |
11,02 |
23,44 |
28,81 |
37,17 |
EBITDA1,2 |
-0,49 |
-0,13 |
0,26 |
0,84 |
6,02 |
8,65 |
7,67 |
EBITDA-Marge3 |
-7,49 |
-1,75 |
3,18 |
7,62 |
25,68 |
30,02 |
|
EBIT1,4 |
-0,72 |
-0,93 |
-0,54 |
-0,43 |
4,53 |
6,00 |
5,03 |
EBIT-Marge5 |
-11,01 |
-12,52 |
-6,60 |
-3,90 |
19,33 |
20,83 |
13,53 |
Jahresüberschuss1 |
-1,25 |
-1,46 |
-0,83 |
-0,69 |
4,11 |
4,86 |
3,91 |
Netto-Marge6 |
-19,11 |
-19,65 |
-10,15 |
-6,26 |
17,53 |
16,87 |
10,52 |
Cashflow1,7 |
1,02 |
-0,66 |
0,17 |
0,76 |
4,77 |
8,04 |
6,29 |
Ergebnis je Aktie8 |
-4,95 |
-5,78 |
-2,81 |
-2,37 |
13,45 |
14,34 |
11,58 |
Dividende8 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
Quelle: boersengefluester.de und Firmenangaben
Geschäftsbericht 2023 - Kostenfrei herunterladen. ![](/wp-content/uploads/assets/icon/pdf_24x24.png)
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de
Wirtschaftsprüfer: B-S-H Collegen
|
INVESTOR-INFORMATIONEN |
©boersengefluester.de |
Limes Schlosskliniken |
WKN |
Kurs in € |
Einschätzung |
Börsenwert in Mio. € |
A0JDBC |
378,000 |
Kaufen |
110,83 |
KGV 2025e |
KGV 10Y-Ø |
BGFL-Ratio |
Shiller-KGV |
22,37 |
22,24 |
1,01 |
80,51 |
KBV |
KCV |
KUV |
EV/EBITDA |
7,33 |
17,61 |
2,98 |
14,65 |
Dividende '22 in € |
Dividende '23 in € |
Div.-Rendite '23 in % |
Hauptversammlung |
0,00 |
0,00 |
0,00 |
10.06.2024 |
Q1-Zahlen |
Q2-Zahlen |
Q3-Zahlen |
Bilanz-PK |
|
03.09.2024 |
|
13.05.2024 |
Abstand 60Tage-Linie |
Abstand 200Tage-Linie |
Performance YtD |
Performance 52 Wochen |
4,01% |
18,92% |
33,10% |
3,85% |
|
|